You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: April 26, 2024

Claims for Patent: 6,692,699

✉ Email this page to a colleague

« Back to Dashboard

Summary for Patent: 6,692,699

Title:	Biochemical blocking layer for liquid crystal assay
Abstract:	A rubbed substrate structure for use in a liquid crystal assay device, includes: a biochemical blocking compound chemically immobilized on a surface of one side of a support forming a biochemical blocking layer; and a biomolecule recognition agent deposited on the side of the support containing the biochemical blocking layer. The biomolecule recognition agent includes a recognition site capable of selectively recognizing a target species to be detected by the liquid crystal assay device. Additionally, the surface of the side of the support containing the biochemical blocking layer is rubbed such that it possesses features that drive a uniform anchoring of liquid crystals when the liquid crystals contact the side of the support containing the biochemical blocking layer. A method for preparing a rubbed substrate structure for use in a liquid crystal assay device, optical cells for use in a liquid crystal assay, liquid crystal assay devices, kits for use in a liquid crystal assay, and methods for detecting the presence of a target species using a liquid crystal assay device are also disclosed.
Inventor(s):	Abbott; Nicholas L. (Madison, WI), Kim; Seung-Ryeol (Madison, WI)
Assignee:	Wisconsin Alumni Research Foundation (Madison, WI)
Application Number:	09/784,679
Patent Claims:	1. A rubbed substrate structure for use in a liquid crystal assay device, comprising: (a) a biochemical blocking compound chemically i mobilized on a support thereby forming a biochemical blocking layer; and (b) a biomolecule recognition agent deposited on the same side of the support as the biochemical blocking layer, wherein a surface of the biochemical blocking layer is rubbed surface that possesses features that drive a uniform anchoring of liquid crystals Is when the liquid crystals contact the rubbed surface, wherein the biochemical blocking layer resists non-specific adsorption of non-target species, wherein the biomolecule recognition agent is immobilized on the support by being bonded to the biochemical blocking compound, and further wherein the biomolecule recognition agent com rises a recognition site capable of selectively recognizing a target species. 2. The rubbed substrate structure for use in a liquid crystal assay device according to claim 1, wherein the biomolecule recognition agent is deposited on the rubbed surface. 3. The rubbed substrate structure for use in a liquid crystal assay device according to claim 1, wherein the biomolecule recognition agent is deposited on the same side of the support as the biochemical blocking layer before the biochemical blocking layer is rubbed. 4. The rubbed substrate structure for use in a liquid crystal assay device according to claim 1, wherein the biochemical blocking compound is immobilized on the support by crosslinking with a crosslinking agent. 5. The rubbed substrate structure for use in a liquid it crystal assay device according to claim 4, wherein the crosslinking gent is glutaraldehyde. 6. The rubbed substrate structure for use in a liquid crystal assay device according to claim 1, wherein the biochemical locking compound is immobilized on the support by being bonded to a bifunctional spacer compound, wherein the bifunctional spacer compound is bonded to a surface modifying compound and the surface modifying compound is bonded to a functionality on the surface of the support. 7. The rubbed substrate structure for use in a liquid crystal assay device according to claim 1, wherein the biochemical blocking compound comprises a serum albumin and the biomolecule recognition agent i an immunoglobulin, a portion of an immunoglobulin, a peptide, a polypeptide, a carbohydrate, a fragment of RNA, or a fragment of DNA. 8. The rubbed substrate structure for use in a liquid crystal assay device according to claim 1, wherein the biochemical locking compound comprises bovine serum albumin and the biomolecule recognition agent is capable of recognizing and binding peptides, polypeptides, DNA, RNA, DNA fragments, RNA fragments or a binding domain associated with a protein, a virus, a bacteria, or a microscopic pathogen. 9. The rubbed substrate structure for use in a liquid crystal assay device according to claim 1, wherein at lea t two regions of the rubbed surface are rubbed under different pressures, speeds, or for different lengths whereby the at least two regions of the rubbed surface have different sensitivities towards the target species. 10. A kit for use in a liquid crystal assay, comprising: (a) at least one rubbed substrate structure according to claim 1; (b) a second surface that uniformly anchors liquid crystals; (c) a spacing material adapted to be placed between the rubbed substrate and the second surface that uniformly anchors liquid crystals; and (d) a liquid crystal compound. 11. The kit for use in a liquid crystal assay according to claim 10, wherein the liquid crystal is 4-cyano-4'-pentylbiphenyl. 12. The kit for use in a liquid crystal assay according to claim 10, wherein the at least one rubbed substrate structure, the second surface that uniformly anchors liquid crystals, and the spacing material are preassembled into an optical cell. 13. A kit for use in detecting the presence of a target species in a sample, the kit comprising: at least one rubbed substrate structure according to claim 1 and a liquid crystal compound. 14. The rubbed substrate structure for use in a liquid crystal assay device according to claim 1, wherein the biochemical blocking layer is a serum albumin. 15. The rubbed substrate structure for use in a liquid crystal assay device according to claim 14, wherein the serum albumin is bovine serum albumin. 16. The rubbed substrate structure for use in a liquid crystal assay device according to claim 14, wherein the serum albumin is human serum albumin, rodent serum albumin, canine serum albumin, feline serum albumin, porcine serum albumin, equine serum albumin or rabbit serum albumin. 17. The rubbed substrate structure for use in a liquid crystal assay device according to claim 1, wherein the sup ort comprises glass. 18. The rubbed substrate structure for use in a liquid crystal assay device according to claim 1, wherein the support comprises silica. 19. The rubbed substrate structure for use in a liquid crystal assay device according to claim 1, wherein the biomolecule recognition agent comprises a portion of an immunoglobulin, a peptide, a protein, a carbohydrate, a fragment of RNA or a fragment of DNA.

Details for Patent 6,692,699

Subscribe to access the full database, or Try a Trial
Applicant	Tradename	Biologic Ingredient	Dosage Form	BLA	Approval Date	Patent No.	Expiredate
Grifols Therapeutics Llc	ALBUKED, PLASBUMIN-20, PLASBUMIN-25, PLASBUMIN-5	albumin (human)	For Injection	101138	10/21/1942	⤷ Try a Trial	2020-02-16
Baxalta Us Inc.	BUMINATE, FLEXBUMIN	albumin (human)	Injection	101452	03/03/1954	⤷ Try a Trial	2020-02-16
Csl Behring Ag	ALBURX	albumin (human)	Injection	102366	07/23/1976	⤷ Try a Trial	2020-02-16
Grifols Biologicals Llc	ALBUTEIN	albumin (human)	Injection	102478	08/15/1978	⤷ Try a Trial	2020-02-16
Instituto Grifols, S.a.	HUMAN ALBUMIN GRIFOLS	albumin (human)	Injection	103352	02/17/1995	⤷ Try a Trial	2020-02-16
>Applicant	>Tradename	>Biologic Ingredient	>Dosage Form	>BLA	>Approval Date	>Patent No.	>Expiredate

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.